BKSY three-lens brief
Evidence-based stock research on BKSY. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -3.98% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved -3.98% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $38.42 — 85% above current (8 analysts).
- Negative free cash flow last quarterly (-$71.45M).
BKSY closed at $20.75 (-3.98%) as of 2026-09-11. Market cap: $849.19M. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $38.42 — 85% above current (8 analysts).. Concerns: moved -3.98% yesterday.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $33.32M, net income -$20.83M, free cash flow -$71.45M.
Why three lenses on BKSY, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BKSYacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BKSY" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BKSY brief"></iframe>